Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services....
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' o
Target Price
The average target price of LALPATHLAB.NS is 3320 and suggests 136% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation
Buy
Sell